94 related articles for article (PubMed ID: 20395094)
1. Safety and tolerability of iobitridol in general and in patients with risk factors: results in more than 160,000 patients.
Maurer M; Heine O; Wolf M; Freyhardt P; Schnapauff D; Hamm B
Eur J Radiol; 2011 Nov; 80(2):357-62. PubMed ID: 20395094
[TBL] [Abstract][Full Text] [Related]
2. Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.
Wendt-Nordahl G; Rotert H; Trojan L; Michel MS; Peters CR; Alken P; Knoll T
Med Princ Pract; 2006; 15(5):358-61. PubMed ID: 16888393
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and diagnostic value of gadoteric acid in the general population and in patients with risk factors: results in more than 84,000 patients.
Maurer M; Heine O; Wolf M; Durmus T; Wagner M; Hamm B
Eur J Radiol; 2012 May; 81(5):885-90. PubMed ID: 21555197
[TBL] [Abstract][Full Text] [Related]
4. Safety of iobitridol in the general population and at-risk patients.
Vogl TJ; Honold E; Wolf M; Mohajeri H; Hammerstingl R
Eur Radiol; 2006 Jun; 16(6):1288-97. PubMed ID: 16429272
[TBL] [Abstract][Full Text] [Related]
5. Results of the safety and efficacy of iobitridol in more than 61,000 patients.
Petersein J; Peters CR; Wolf M; Hamm B
Eur Radiol; 2003 Aug; 13(8):2006-11. PubMed ID: 12942302
[TBL] [Abstract][Full Text] [Related]
6. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital.
Mortelé KJ; Oliva MR; Ondategui S; Ros PR; Silverman SG
AJR Am J Roentgenol; 2005 Jan; 184(1):31-4. PubMed ID: 15615946
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the new iodinated nonionic low-osmolality contrast medium Iobitridol (Xenetix) in coronary and ventricular angiography.
Lefevre T; Funck F; Aliot E; Ethevenot B
Acta Radiol Suppl; 1996; 400():75-80. PubMed ID: 8619358
[TBL] [Abstract][Full Text] [Related]
10. Clinical tolerance and diagnostic efficacy of iobitridol in contrast-enhanced CT in children.
Smets A; Shaw D
Acta Radiol Suppl; 1996; 400():65-7. PubMed ID: 8619355
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of iobitridol versus iohexol for contrast-enhanced CT of the head.
Drouillard J; Froment JC; Frija G; Caille JM; Gandon Y; Clarisse J; Gaston A
Acta Radiol Suppl; 1996; 400():56-61. PubMed ID: 8619353
[TBL] [Abstract][Full Text] [Related]
12. Safety Analysis of Iobitridol as a Nonionic Contrast Medium: A Postmarketing Multicenter Surveillance Study With 94,960 Patients Almost 20 Years After Introduction.
Gorodetski B; Heine O; Wolf M; Collettini F; Hamm B; Darmon-Kern E; Penzkofer T
Invest Radiol; 2020 Mar; 55(3):144-152. PubMed ID: 31977601
[TBL] [Abstract][Full Text] [Related]
13. Iobitridol 300 compared to iopromide 300--a double-blind randomized phase-III study of clinical tolerance in total body CT.
Hoogewoud HM; Woessmer B
Acta Radiol Suppl; 1996; 400():62-4. PubMed ID: 8619354
[TBL] [Abstract][Full Text] [Related]
14. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
Wiklund LM; Brolin I; Sjöholm K
Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
[TBL] [Abstract][Full Text] [Related]
15. Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance.
Voth M; Rosenberg M; Breuer J
Invest Radiol; 2011 Nov; 46(11):663-71. PubMed ID: 21623211
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the clinical safety and efficacy of iobitridol (Xenetix) in intravenous urography.
Fournier PJ; Steinbrich W; Freitag P; Voegeli E
Eur J Radiol; 1996 Nov; 23(3):185-9. PubMed ID: 9003922
[TBL] [Abstract][Full Text] [Related]
17. Iobitridol 250 vs iohexol 240 in phlebography of th lower limbs. A double-blind clinical trial.
Chagnaud C; Moulin G; Bartoli JM; Rousseau H; Railhac JJ; Lyonnet D
Acta Radiol Suppl; 1996; 400():89-91. PubMed ID: 8619362
[TBL] [Abstract][Full Text] [Related]
18. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
Schmiedel E
Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter analysis of tolerance and clinical safety of the extracellular MR contrast agent gadobenate dimeglumine (MultiHance)].
Herborn CU; Jäger-Booth I; Lodemann KP; Spinazzi A; Goyen M
Rofo; 2009 Jul; 181(7):652-7. PubMed ID: 19291607
[TBL] [Abstract][Full Text] [Related]
20. The delayed adverse reactions of low osmolar contrast media.
Higashi TS; Katayama M
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Nov; 50(11):1359-66. PubMed ID: 2087395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
